drugset
drugset / Trial / NCT01173536

A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects

NCT01173536 ↗

Phase 1 Completed 61 enrolled Genentech, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase I, single-center, three-arm, randomized, double-blind, active- and placebo-controlled study to investigate the effect of GDC-0449 on the QT/QTc interval in healthy female subjects of non-childbearing potential.

Timeline

Start
2010-08-25
Primary completion
2011-03-18
Completion
2011-03-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule — Oral
Subject Vismodegib Small molecule — Oral

Indications

No indication recorded.